In this study, R-2HG was used to directly inhibiting FTO in AML and glioma cells, which resulted in increased methylation and decreased expression of c-MYC and CEBPA mRNAs, blocking proliferation, cell cycle, and inducing apoptosis in AML and glioma cells [37]. Here, MYC is linked to acute myeloid leukemia.